English
On July 18, 2025, Geneham Pharmaceutical Co., Ltd. successfully completed the FAMI-QS certification. This milestone marks that the company has passed this rigorous international certification with high quality for 7 consecutive years since 2018.
FAMI-QS, short for Feed Additives and Pre-mixtures Quality System (European Standard), is a mandatory certification implemented by the European Union to enforce feed regulations. Its core objective is to ensure that the production of feed additives and pre-mixed feeds complies with strict hygiene and safety standards. Integrating the requirements of multiple quality management systems such as ISO9001 and HACCP, this certification emphasizes strict control throughout the entire process—from raw material procurement to product transportation—and enjoys wide recognition in the EU and global feed industry.
Since its establishment, Geneham Pharmaceutical Co., Ltd. has always regarded quality as the core of its development. The company not only conducts strict supervision and inspection on every production process to ensure the accuracy of product quality and related testing data but also proactively introduces advanced international quality management concepts and standards to continuously improve its production and management capabilities. As early as 2018, the company obtained the FAMI-QS certification for the first time. Over the past 7 years, it has persisted in optimizing its internal management system and enhancing product quality. With a high level of self-discipline and strict self-requirements, the company has successfully passed the certification review with high quality for consecutive years, winning wide recognition from customers at home and abroad.
The successful renewal of the FAMI-QS certification this time is a strong recognition of Geneham Pharmaceutical Co., Ltd.’s long-term commitment to the high-quality development strategy. In the future, the company will continue to uphold its development philosophy of "Innovative Health Solutions". Guided by international standards, it will increase investment in R&D, production, and quality management, provide higher-quality and safer products and services to global customers, and contribute more to promoting the healthy development of the industry.
